Ads
related to: who should not take zantac
Search results
Results from the WOW.Com Content Network
Shortly afterwards, lawsuits began piling up from people who said they developed cancer after taking Zantac. Plaintiffs said the companies knew, or should have known, that ranitidine posed a ...
The jury found that Valadez proved that she had taken Zantac, but not that it was a cause of her cancer. First approved in 1983, Zantac became the world's best selling medicine in 1988 and one of ...
Some tests showed that Zantac's active ingredient, ranitidine, could degrade into NDMA over time or when exposed to heat. The U.S. Food and Drug Administration asked manufacturers to pull the drug ...
Addiction to taking it ("a habit") was how some of its users described Zantac. [10] The focus of Glaxo, its manufacturer, was to gain market share "from Zantac competitors like Tagamet." [9] Cimetidine, sold under the brand name Tagamet among others, was listed in 2020 as an alternative to Zantac. [11]
Ranitidine, previously sold under the brand name Zantac [a] among others, is a medication used to decrease stomach acid production. [12] It was commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. [12]
Ranitidine (Zantac) 2020 Worldwide Found to spontaneously break down into the carcinogen N-nitrosodimethylamine. Rapacuronium (Raplon) 2001 US, multiple markets Withdrawn in many countries because of risk of fatal bronchospasm. [2] Remoxipride: 1993 UK, others Aplastic anemia. [3] rhesus rotavirus vaccine-tetravalent (RotaShield) 1999 US
(Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause ...
First approved in 1983, Zantac became the world's best-selling medicine in 1988 and one of the first to top $1 billion in annual sales. It was originally marketed by a forerunner of GSK and later ...
Ads
related to: who should not take zantac